These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36934527)

  • 21. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairment.
    Yukawa T; Yamashita T; Imaeda T; Kakei H; Hashizume S; Nakamura M; Daini M; Okabe A; Nakashima K; Harada A; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2023 Feb; 79():117150. PubMed ID: 36640594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 24. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.
    Sapkota K; Dore K; Tang K; Irvine M; Fang G; Burnell ES; Malinow R; Jane DE; Monaghan DT
    Biochem Pharmacol; 2019 Jan; 159():140-153. PubMed ID: 30503374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
    Vizi ES; Kisfali M; Lőrincz T
    Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The σ-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor.
    Balasuriya D; Stewart AP; Edwardson JM
    J Neurosci; 2013 Nov; 33(46):18219-24. PubMed ID: 24227730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
    Monaghan DT; Irvine MW; Costa BM; Fang G; Jane DE
    Neurochem Int; 2012 Sep; 61(4):581-92. PubMed ID: 22269804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia.
    Vieira MM; Schmidt J; Ferreira JS; She K; Oku S; Mele M; Santos AE; Duarte CB; Craig AM; Carvalho AL
    Neurobiol Dis; 2016 May; 89():223-34. PubMed ID: 26581639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Laube B; Jane DE; Monaghan DT
    Neuropharmacology; 2012 Mar; 62(4):1730-6. PubMed ID: 22155206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRPing into excitotoxic neuronal death.
    Green MV; West AE
    Cell Calcium; 2021 Jan; 93():102331. PubMed ID: 33341523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
    Wang H; Lv S; Stroebel D; Zhang J; Pan Y; Huang X; Zhang X; Paoletti P; Zhu S
    Neuron; 2021 Aug; 109(15):2443-2456.e5. PubMed ID: 34186027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.
    Liu Y; Wong TP; Aarts M; Rooyakkers A; Liu L; Lai TW; Wu DC; Lu J; Tymianski M; Craig AM; Wang YT
    J Neurosci; 2007 Mar; 27(11):2846-57. PubMed ID: 17360906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GluN2A Subunit-Containing NMDA Receptors Are the Preferential Neuronal Targets of Homocysteine.
    Sibarov DA; Abushik PA; Giniatullin R; Antonov SM
    Front Cell Neurosci; 2016; 10():246. PubMed ID: 27847466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
    Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
    Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.